Medistim ASA reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was NOK 135.62 million compared to NOK 141.82 million a year ago. Revenue was NOK 135.62 million compared to NOK 141.82 million a year ago. Net income was NOK 19.11 million compared to NOK 32.48 million a year ago. Basic earnings per share from continuing operations was NOK 1.05 compared to NOK 1.78 a year ago. Diluted earnings per share from continuing operations was NOK 1.04 compared to NOK 1.78 a year ago.
For the full year, sales was NOK 526.36 million compared to NOK 491.94 million a year ago. Revenue was NOK 526.36 million compared to NOK 491.94 million a year ago. Net income was NOK 103.82 million compared to NOK 113.97 million a year ago. Basic earnings per share from continuing operations was NOK 5.68 compared to NOK 6.25 a year ago. Diluted earnings per share from continuing operations was NOK 5.67 compared to NOK 6.24 a year ago.